OCT 05, 2016 6:19 PM PDT

Scientists Learn More About Psoriasis Development

WRITTEN BY: Kara Marker
While scientists know that there is some genetic connection that explains why some people develop psoriasis, little is known about any details. However, a new study provides proof for involvement of a new gene, called TREX2.
Image credit: qsota.com
Psoriasis is characterized by itching, burning, and stinging lesions that build up due to abnormally fast-growing skin cells, often on the elbows, knees, or scalp. The disease affects approximately two percent of the population, it is not contagious or infectious, and there is no known cure. The new study from the Universidad de Barcelona, published in Journal of Investigative Dermatology, shows that TREX2 seems to be at least partly responsible for “provoking the characteristic inflammatory response” of psoriasis.

TREX2 genes code for an endonuclease that maintains the stability of the entire genome, including repair mechanisms like DNA degradation. The gene seems to have a complicated role in the body; previous studies of mice lacking TREX2 showed them to be highly susceptible to ultraviolet light-induced carcinogenesis, and the present study provides evidence that the same gene is highly expressed in the skin of psoriasis patients.

“The release of several signals by skin cells that are dying contributes to the creation and spreading of the chronic immune response and hyper-proliferation and irregular differentiation of epidermis,” said first author Joan Manils. Using biopsies from humans with and without psoriasis along with mice models of psoriasis with both normal and deficient TREX2, Manils and the research team investigated the true function of TREX2 in cases of psoriasis. 

They ultimately found that psoriasis skin cells had a high increase of TREX2 expression, mainly from the cell nuclei of keratinocytes, the most abundant cells on the skin, that are growing and dying abnormally. 

With a clearer connection drawn between TREX2 and psoriasis, the researchers from the Universidad de Barcelona next plan to investigate the details surrounding the connection: the role of TREX2 in the development and maintenance of psoriasis. 

"Most of the current treatments are aimed at blocking the action of the immune system and if they have good results, these treatments are chronic and involve the immune response of the sick person," said co-author Francisco Ciruela. However, in the future, a potential treatment for psoriasis could be to target TREX2, rather than the entire immune system. 
 


Source: Universidad de Barcelona, National Psoriasis Foundation, Nature Methods
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 17, 2020
Immunology
Nervous Protein Neuromedin B May Prevent Immune Reactivity
AUG 17, 2020
Nervous Protein Neuromedin B May Prevent Immune Reactivity
A protein produced by the nervous system seems to play a role in regulating the immune system. For people with inflammat ...
SEP 03, 2020
Immunology
A Low-Cost COVID-19 Treatment, Made in Horses
SEP 03, 2020
A Low-Cost COVID-19 Treatment, Made in Horses
Researchers in Costa Rica are turning to horses as an unlikely source of potential therapeutic antibodies against COVID- ...
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 10, 2020
Immunology
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
NOV 10, 2020
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
In the middle of 2020, yet another deadly Ebola outbreak was reported in the Democratic Republic of the Congo - the 11th ...
NOV 12, 2020
Health & Medicine
Measles Cases and Deaths Surge Worldwide
NOV 12, 2020
Measles Cases and Deaths Surge Worldwide
Today, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) released a stat ...
Loading Comments...